by European Public Health Alliance | Dec 2, 2019 | Consultation Responses, Opinion, Position & Policy Papers
In the context of an economically-growing and dynamic European society, health becomes a prerequisite for competitiveness, positive demographic change and progress within European countries. Health is a crucial factor that defines an individual European’s personal...
by European Public Health Alliance | Jul 2, 2019 | Consultation Responses
Click on the button below to read EPHA’s response to the public consultation on “EMA Regulatory Science to 2025”. DOWNLOAD CONSULTATION...
by European Public Health Alliance | Mar 12, 2019 | Consultation Responses
EPHA has joined the Antibiotic Resistance Coalition to call on the WHO UN Inter-agency Coordination Group on Antimicrobial Resistance to stress the need for an urgent response to the challenge of AMR, increased investment, measurable targets and accountability...
by European Public Health Alliance | Jan 31, 2019 | Consultation Responses
Click on the button below to read EPHA’s response to the public consultation “How the European Medicines Agency engages with medicine producers before they apply for authorisations to market their medicines in the EU – Invitation to comment within the...
by EPHA | Oct 4, 2018 | Consultation Responses
Civil society’s proposal for Horizon Europe, the next EU research framework programme High prices of new drugs for cancer, hepatitis C and rare diseases in Europe have attracted great media and public attention and have brought the debate about access to medicines...
by EPHA | May 4, 2017 | Consultation Responses
Click on the button below to read EPHA’s response to the OECD online consultation on sustainable access to innovative therapies. Please note that the consultation response included EPHA’s Briefing Will fast-tracking new medicines improve affordability? DOWNLOAD...
